Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Pratima Nangia-Makker
Nano-Targeted Delivery of Rad6/Translesion Synthesis Inhibitor for Triple Negative Breast Cancer Therapy
Molecular Cancer Therapeutics
Cancer Research
Oncology
Regulation of Prostate Cancer Progression by Galectin-3
American Journal of Pathology
Forensic Medicine
Pathology
Related publications
Targeted Therapies in Triple-Negative Breast Cancer: Failure and Future
Women's Health
Medicine
Triple-Negative Breast Cancer
Development of Biodegradable PLGA Nanoparticles Surface Engineered With Hyaluronic Acid for Targeted Delivery of Paclitaxel to Triple Negative Breast Cancer Cells
Materials Science and Engineering C
Mechanics of Materials
Materials Science
Condensed Matter Physics
Mechanical Engineering
Platinum-Based Therapy for Triple-Negative Breast Cancer Treatment: A Meta-Analysis
Molecular and Clinical Oncology
Cancer Research
Oncology
Delivery of Anti-miRNA for Triple Negative Breast Cancer Therapy Using RNA Nanoparticles Targeting to Stem Cell Marker CD133
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Triple Negative Breast Cancer: Breast Cancer Research in Evolution
Breast Disease
Medicine
Cancer Research
Oncology
Targeting MYC for Triple-Negative Breast Cancer Treatment
Oncoscience
Cancer Research
Oncology
Targeted Delivery for Breast Cancer Therapy: The History of Nanoparticle-Albumin-Bound Paclitaxel
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology
